Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer

被引:47
作者
Al-Bazz, Yousif O. [1 ]
Underwood, James C. E. [2 ]
Brown, Barry L. [1 ]
Dobson, Pauline R. M. [1 ]
机构
[1] Univ Sheffield, Sch Med, Sect Endocrinol & Reprod, Acad Unit Endocrinol, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England
关键词
Akt; Phospho-Akt; BAD; Immunohistochemistry; Breast cancer; PROTEIN-KINASE-B; ESTROGEN-RECEPTOR-ALPHA; PHOSPHATIDYLINOSITOL-3-OH KINASE; MAMMARY EPITHELIUM; MULTIPLE-MYELOMA; CARCINOMA CELLS; ACTIVATION; APOPTOSIS; PHOSPHORYLATION; SURVIVAL;
D O I
10.1016/j.ejca.2008.11.044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptotic markers in breast cancer are reported to have prognostic significance. The aim of this study was to assess the prognostic value of Akt, phospho-Akt and BAD expression in primary tumours from breast cancer patients. Expression of phospho-Akt did not correlate with menopausal status, nodal involvement or tumour size, although there was a significant correlation between phospho-Akt and oestrogen receptor status and tumour grade. No association was found between phospho-Akt and BAD. However, a significant correlation was found between Akt and BAD. Akt and phospho-Akt expression did not correlate with either disease-free survival (DFS) or overall survival (OS). Conversely, BAD immunostaining correlated significantly with increasing tumour size and with oestrogen receptor (ER) immunostaining in both frozen and paraffin sections. Expression of BAD appeared to be nucleolar in addition to its cytoplasmic and nuclear staining. Comparison of immunohistochemical staining on frozen sections and paraffin sections showed a reasonable concordance in Akt and BAD immunoreactivity. However, the results showed for the first time that strong BAD expression is related to a favourable prognosis but is not an independent prognostic factor. in conclusion, these results could provide the basis for understanding how Akt, phospho-Akt and BAD expression contributes to the prognosis of invasive breast cancer. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:694 / 704
页数:11
相关论文
共 50 条
  • [1] Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
    Aleskandarany, Mohammed A.
    Rakha, Emad A.
    Ahmed, Mohamed A.
    Powe, Desmond G.
    Ellis, Ian O.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 407 - 416
  • [2] Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
    Mohammed A. Aleskandarany
    Emad A. Rakha
    Mohamed A. Ahmed
    Desmond G. Powe
    Ian O. Ellis
    Andrew R. Green
    Breast Cancer Research and Treatment, 2011, 127 : 407 - 416
  • [3] Immunohistochemical Detection of Phospho-Akt, Phospho-BAD, HER2 and Oestrogen Receptors α and β in Malaysian Breast Cancer Patients
    Seow, Heng Fong
    Yip, Wai Kien
    Loh, Hui Woon
    Ithnin, Hairuszah
    Por, Patricia
    Rohaizak, Mohammad
    PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (02) : 239 - 248
  • [4] Immunohistochemical expression of phospho-Akt in uveal melanoma
    Saraiva, VS
    Caissie, AL
    Segal, L
    Edelstein, C
    Burnier, MN
    MELANOMA RESEARCH, 2005, 15 (04) : 245 - 250
  • [5] Immuno-analysis of phospho-Akt in primary human breast cancers
    Al-Bazz, Y. O.
    Brown, B. L.
    Underwood, J. C. E.
    Stewart, R. L.
    Dobson, P. R. M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (05) : 1159 - 1167
  • [6] Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
    Massihnia, Daniela
    Avan, Amir
    Funel, Niccola
    Maftouh, Mina
    van Krieken, Anne
    Granchi, Carlotta
    Raktoe, Rajiv
    Boggi, Ugo
    Aicher, Babette
    Minutolo, Filippo
    Russo, Antonio
    Leon, Leticia G.
    Peters, Godefridus J.
    Giovannetti, Elisa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [7] Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms
    Grimwade, Lizz F.
    Happerfield, Lisa
    Tristram, Colin
    McIntosh, Gary
    Rees, Mark
    Bench, Anthony J.
    Boyd, Elaine M.
    Hall, Marie
    Quinn, Amy
    Piggott, Nigel
    Scorer, Paul
    Scott, Mike A.
    Erber, Wendy N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (04) : 495 - 506
  • [8] Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
    Daniela Massihnia
    Amir Avan
    Niccola Funel
    Mina Maftouh
    Anne van Krieken
    Carlotta Granchi
    Rajiv Raktoe
    Ugo Boggi
    Babette Aicher
    Filippo Minutolo
    Antonio Russo
    Leticia G. Leon
    Godefridus J. Peters
    Elisa Giovannetti
    Journal of Hematology & Oncology, 10
  • [9] Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
    Kitano, Haruhisa
    Chung, Joon-Yong
    Ylaya, Kris
    Conway, Catherine
    Takikita, Mikiko
    Fukuoka, Junya
    Doki, Yoshinori
    Hanaoka, Jun
    Hewitt, Stephen M.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (05) : 335 - 346
  • [10] Enhanced expression of phospho-Akt by electro-acupuncture in normal rat brain
    Wang, SJ
    Omori, N
    Li, F
    Zhang, WR
    Jin, G
    Hamakawa, Y
    Sato, K
    Nagano, I
    Shoji, M
    Abe, K
    NEUROLOGICAL RESEARCH, 2002, 24 (07) : 719 - 724